The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.

The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...

Two new clinics that pay people for their plasma have opened in Fredericton and Saint John, following a location that was ...

If you’re on the fence about investing in CRISPR Therapeutics AG, Grifols or S.A. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

Your business's website is likely the first and strongest impression you'll make with millions of potential customers online, so you want to ensure it's a good one. There are many popular ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Spanish plasma-based medicines maker Grifols (MCE: GRF) has announced disappointing top-line data from its Phase III PRECIOSA clinical trial evaluating the potential of long-term albumin treatment ...